Suppr超能文献

奥司他韦耐药的大流行(H1N1)2009 流感在一个重症患者中:澳大利亚首例。

Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.

机构信息

Division of Microbiology and Infectious Diseases, PathWest Laboratory Medicine WA, Perth, WA.

出版信息

Med J Aust. 2010 Feb 1;192(3):166-8. doi: 10.5694/j.1326-5377.2010.tb03459.x.

Abstract

After a 10-day course of oral oseltamivir for pandemic (H1N1) 2009 influenza infection, a renal transplant recipient developed rapid-onset severe primary viral pneumonia due to oseltamivir-resistant virus. Respiratory failure progressed despite high-dose oral oseltamivir, nebulised zanamivir and cessation of immunosuppressive medications, but his condition improved with intravenous zanamivir. He subsequently died of non-respiratory complications. This is the first case of oseltamivir-resistant pandemic (H1N1) 2009 in Australia and the first report of resistance in a solid organ transplant recipient.

摘要

一名肾移植受者在接受了为期 10 天的口服奥司他韦治疗大流行(H1N1)2009 流感感染后,因奥司他韦耐药病毒而迅速发生严重原发性病毒性肺炎。尽管给予了大剂量口服奥司他韦、雾化吸入扎那米韦和停用免疫抑制剂,但呼吸衰竭仍在进展,然而,他的病情在接受静脉用扎那米韦治疗后有所改善。随后,他死于非呼吸相关并发症。这是澳大利亚首例奥司他韦耐药大流行(H1N1)2009 病例,也是首例在实体器官移植受者中发现耐药的报告。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验